CORRESP Filing
Bio Green Med Solution, Inc.
Date: July 24, 2025 · CIK: 0001130166 · Accession: 0001641172-25-020819
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288912
Letter
CYCLACEL PHARMACEUTICALS, INC.
Level 10, Tower 11, Avenue 5, The Horizon
Bangsar South City, No. 8, Jalan Kerinchi, 59200, Kuala Lumpur, Malaysia
July 24, 2025
Securities and Exchange Commission
Division of Corporation Finance
F Street, N.E.
Washington, DC 20549
via EDGAR
RE: Cyclacel Pharmaceuticals, Inc. (CIK0001130166)
Registration Statement on Form S-4
Filed: July 24, 2025
Securities Act File No.: 333-288912
Request for Acceleration of Effectiveness
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Cyclacel Pharmaceuticals, Inc. (the "Registrant") hereby respectfully requests acceleration of its Registration Statement on Form S-4 (File No. 333-288912), filed on July 24, 2025, so that it will become effective at 5:00 p.m. (Eastern time) on July 25, 2025, or as soon as practicable thereafter.
If you have any questions, or require any additional information, please do not hesitate to email Debbie Klis, the Registrant's outside counsel, at debbie.klis@rimonlaw.com or phone on 202-935-3390.
Very
truly yours,
Cyclacel
Pharmaceuticals, Inc.
Show Raw Text
CORRESP 1 filename1.htm CYCLACEL PHARMACEUTICALS, INC. Level 10, Tower 11, Avenue 5, The Horizon Bangsar South City, No. 8, Jalan Kerinchi, 59200, Kuala Lumpur, Malaysia July 24, 2025 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 via EDGAR RE: Cyclacel Pharmaceuticals, Inc. (CIK0001130166) Registration Statement on Form S-4 Filed: July 24, 2025 Securities Act File No.: 333-288912 Request for Acceleration of Effectiveness Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Cyclacel Pharmaceuticals, Inc. (the "Registrant") hereby respectfully requests acceleration of its Registration Statement on Form S-4 (File No. 333-288912), filed on July 24, 2025, so that it will become effective at 5:00 p.m. (Eastern time) on July 25, 2025, or as soon as practicable thereafter. If you have any questions, or require any additional information, please do not hesitate to email Debbie Klis, the Registrant's outside counsel, at debbie.klis@rimonlaw.com or phone on 202-935-3390. Very truly yours, Cyclacel Pharmaceuticals, Inc. By: /s/ Datuk Dr. Doris Wong Datuk Dr. Doris Wong Chief Executive Officer